CRISPR-Cas9 has demonstrated considerable clinical potential across a range of therapeutic applications, particularly for selected monogenic disorders in which the strongest clinical evidence is currently available.
M. D. Badru, Verity Ghansah, Ifeoluwa Oyinkansola Adesanya et al.· Australian Journal of Biomed...· 0 citations
The findings underscore the need for responsible AI governance, robust clinical oversight, multidisciplinary collaboration, multidisciplinary collaboration, and longitudinal research to better understand and mitigate the long-term mental health consequences of generative AI.
Heidi Heather Henry Heimbruch, D. Eke, Lauren Henry et al.· Journal of Life Science and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.